ArticleJournal of inflammation research2025
Immune Microenvironment Characterization and Machine Learning-Guided Identification of Diagnostic Biomarkers for Ulcerative Colitis.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multi-omics integration analysis based on plasma circulating proteins reveals potential therapeutic targets for ulcerative colitis.Frontiers in molecular biosciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ulcerative colitis (UC) is a chronic inflammatory bowel disease hallmarked by dysregulated immune responses. Current treatments often show limited efficacy, highlighting the need for novel diagnostic and therapeutic approaches. Methods: RNA-Seq data from 495 UC patients and 320 controls (training dataset) and 389 UC patients and 209 controls (testing dataset) were analyzed. Immune cell infiltration was assessed via the ImmuCellAI algorithm, while differential expression analysis and WGCNA were performed to identify key immune-related genes. Moreover, machine learning models, including Random Forest and Best Subset Selection, were used to construct and validate an optimal diagnostic framework. Lastly, the findings were further corroborated using immunohistochemistry conducted on tissue samples from UC patients and controls. Results: Thirteen immune cell types, including B cells, macrophages, and naive CD4+ T cells, were identified as significantly altered in UC. Likewise, cytokines such as IL-10, TGF-β, RORγ, and IL-21 exhibited abnormal expression patterns in UC tissues. WGCNA identified three immune cell-associated gene modules, among which the MEblue, MEturquoise, and MEgrey modules were highly correlated with aberrant immune cells. Additionally, machine learning models identified 99 candidate genes, from which an optimal diagnostic model comprising eight crucial genes (GATA2, IL8, LAT, NOLC1, SMARCA5, SMC3, STX10, ZMIZ1) was constructed, achieving an AUC of 0.964 in the training dataset, 0.926 in the internal test dataset, and 0.884 in the independent test dataset. Functional enrichment analysis revealed associations with inflammatory and immune-regulatory pathways, highlighting their biological relevance. Moreover, the identified eight genes hold translational potential for clinical diagnostics and may serve as a foundation for future precision-targeted therapies in UC. Conclusion: This study highlights alterations in the immune microenvironment in UC and presents an accurate eight-gene diagnostic model, offering the potential for early detection and novel therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.